A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.
Saved in:
| Title: | A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study. |
|---|---|
| Authors: | Singh RSP; Pfizer Research and Development, Cambridge, Massachusetts, USA., Toussi SS; Pfizer Research and Development, New York, New York, USA., Hackman F; Pfizer Research and Development, Tadworth, UK., Shahbazi M; Pfizer Research and Development, New York, New York, USA., Prybylski J; Pfizer Research and Development, Groton, Connecticut, USA., Sahasrabudhe SA; Pfizer Research and Development, Cambridge, Massachusetts, USA., Crownover P; Pfizer Research and Development, Groton, Connecticut, USA., Kadar EP; Pfizer Research and Development, Groton, Connecticut, USA., George BT; Pfizer Research and Development, Groton, Connecticut, USA., Alami NN; Pfizer Research and Development, Groton, Connecticut, USA., Bergman A; Pfizer Research and Development, Groton, Connecticut, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2026 Jul; Vol. 19 (7), pp. e70659. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42433209 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Singh+RSP%22">Singh RSP</searchLink>; Pfizer Research and Development, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Toussi+SS%22">Toussi SS</searchLink>; Pfizer Research and Development, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hackman+F%22">Hackman F</searchLink>; Pfizer Research and Development, Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Shahbazi+M%22">Shahbazi M</searchLink>; Pfizer Research and Development, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Prybylski+J%22">Prybylski J</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Sahasrabudhe+SA%22">Sahasrabudhe SA</searchLink>; Pfizer Research and Development, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Crownover+P%22">Crownover P</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Kadar+EP%22">Kadar EP</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22George+BT%22">George BT</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Alami+NN%22">Alami NN</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Bergman+A%22">Bergman A</searchLink>; Pfizer Research and Development, Groton, Connecticut, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2026 Jul; Vol. 19 (7), pp. e70659. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42433209 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.70659 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70659 Titles: – TitleFull: A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Singh RSP – PersonEntity: Name: NameFull: Toussi SS – PersonEntity: Name: NameFull: Hackman F – PersonEntity: Name: NameFull: Shahbazi M – PersonEntity: Name: NameFull: Prybylski J – PersonEntity: Name: NameFull: Sahasrabudhe SA – PersonEntity: Name: NameFull: Crownover P – PersonEntity: Name: NameFull: Kadar EP – PersonEntity: Name: NameFull: George BT – PersonEntity: Name: NameFull: Alami NN – PersonEntity: Name: NameFull: Bergman A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1752-8062 Numbering: – Type: volume Value: 19 – Type: issue Value: 7 Titles: – TitleFull: Clinical and translational science Type: main |
| ResultId | 1 |